<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Z</submitter><funding>NIBIB NIH HHS</funding><funding>NIH Office of the Director</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><funding>National Institute of Biomedical Imaging and Bioengineering</funding><pagination>1635-1644</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6226330</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(11)</volume><pubmed_abstract>Staphylococcus aureus is the leading cause of life-threatening infections, frequently originating from unknown or deep-seated foci. Source control and institution of appropriate antibiotics remain challenges, especially with infections due to methicillin-resistant S. aureus (MRSA). In this study, we developed a radiofluorinated analog of para-aminobenzoic acid (2-[&lt;sup>18&lt;/sup>F]F-PABA) and demonstrate that it is an efficient alternative substrate for the S. aureus dihydropteroate synthase (DHPS). 2-[&lt;sup>18&lt;/sup>F]F-PABA rapidly accumulated in vitro within laboratory and clinical (including MRSA) strains of S. aureus but not in mammalian cells. Biodistribution in murine and rat models demonstrated localization at infection sites and rapid renal elimination. In a rat model, 2-[&lt;sup>18&lt;/sup</pubmed_abstract><journal>ACS infectious diseases</journal><pubmed_title>Positron Emission Tomography Imaging with 2-[&lt;sup>18&lt;/sup>F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response.</pubmed_title><pmcid>PMC6226330</pmcid><funding_grant_id>DP2-OD006492</funding_grant_id><funding_grant_id>T32 GM092714</funding_grant_id><funding_grant_id>R01 EB020539</funding_grant_id><funding_grant_id>R01 GM102864</funding_grant_id><funding_grant_id>GM-102864</funding_grant_id><funding_grant_id>DP2 OD006492</funding_grant_id><funding_grant_id>R01-EB020539</funding_grant_id><pubmed_authors>Smith-Jones PM</pubmed_authors><pubmed_authors>Ordonez AA</pubmed_authors><pubmed_authors>Daryaee F</pubmed_authors><pubmed_authors>Iuliano JN</pubmed_authors><pubmed_authors>Weinstein EA</pubmed_authors><pubmed_authors>Merino J</pubmed_authors><pubmed_authors>Yoon GE</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Tonge PJ</pubmed_authors><pubmed_authors>Mease RC</pubmed_authors><pubmed_authors>Gogarty KR</pubmed_authors><pubmed_authors>Jain SK</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Kalinda AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Positron Emission Tomography Imaging with 2-[&lt;sup>18&lt;/sup>F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response.</name><description>Staphylococcus aureus is the leading cause of life-threatening infections, frequently originating from unknown or deep-seated foci. Source control and institution of appropriate antibiotics remain challenges, especially with infections due to methicillin-resistant S. aureus (MRSA). In this study, we developed a radiofluorinated analog of para-aminobenzoic acid (2-[&lt;sup>18&lt;/sup>F]F-PABA) and demonstrate that it is an efficient alternative substrate for the S. aureus dihydropteroate synthase (DHPS). 2-[&lt;sup>18&lt;/sup>F]F-PABA rapidly accumulated in vitro within laboratory and clinical (including MRSA) strains of S. aureus but not in mammalian cells. Biodistribution in murine and rat models demonstrated localization at infection sites and rapid renal elimination. In a rat model, 2-[&lt;sup>18&lt;/sup</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2026-05-06T00:23:48.343Z</modification><creation>2019-03-27T00:07:17Z</creation></dates><accession>S-EPMC6226330</accession><cross_references><pubmed>30067329</pubmed><doi>10.1021/acsinfecdis.8b00182</doi></cross_references></HashMap>